UNSPSC 85813205: Introduction of analgesics, hypnotics, sedatives into biliary and pancreatic tract, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of analgesics, hypnotics, sedatives into biliary and pancreatic tract, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0J3NZ

UNSPSC 85813205 Introduction of analgesics, hypnotics, sedatives into biliary and pancreatic tract, percutaneous approach is a Commodity code showing little relevant recent activity in state and local procurement. The code's nominal scope — pharmaceutical administration via percutaneous intervention — does not align with the opportunities posted under it, which reflect a broad range of health and human services unrelated to the specific clinical procedure the code names.

The recent opportunities tagged to this code include virtual urgent care services (Inland Empire Health Plan, RFI, October 31, 2026 response deadline); comprehensive medical director and physician staffing services for EMS, fire departments, and pension boards across multiple states; occupational health screening and occupational medicine services; behavioral health crisis stabilization and treatment programs; recovery audit and billing services for Medicaid and EMS; cancer screening and registry services; employee wellness platform services; and harm reduction infrastructure. State and local issuing bodies include county health authorities (Nevada, Santa Clara, Sedgwick, Solano), municipal health systems (San Mateo, Phoenix, Ocala), county sheriff and fire departments (Boulder, Sarasota, Atlanta), behavioral health departments (Ventura, Santa Clara, Fairfax, Rockland), state health agencies (Texas HHSC, Colorado Department of Human Services, New Jersey Department of Health, Illinois Secretary of State), and special districts (Sourcewell cooperative, H-GAC consortium). The geographic spread spans California, Nevada, Colorado, Texas, Florida, Georgia, Arizona, New York, Kansas, Oregon, and Illinois. The mismatch between the code's billing and administration taxonomy and the clinical services actually being procured suggests this code is being misapplied at the source; procurement personnel appear to be tagging diverse health-system and clinical-staffing opportunities under a code designed for a specific interventional procedure. No opportunities reflect the percutaneous pharmaceutical intervention the code nominally describes. Vendors pursuing opportunities in this code should treat it as a signal to verify scope alignment directly with issuing bodies rather than relying on UNSPSC coding accuracy.